University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Biogen Direct
Change Order Amount: $0
Please note: Biogen Direct, LLC payments are made via AmerisourceBergen Drug Corporation.
The Chief Procurement Officer for this procurement is now John Donato.
The University award process may be delayed up to thirty days as this award goes through a state approval process.
Biogen DirectFrisco, TX
- Amount: An estimated $4,500,000
- Terms: An estimated start date of 2/1/2019 through 6/30/2022
- Renewals: None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, February 1, 2019
The University awarded a contract for Tecfidera (dimethyl fumarate).
Tecfidera (dimethyl fumarate) is an oral medication used to treat relapse-remitting multiple sclerosis (RRMS).
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Biogen Direct is the exclusive distributor and without the purchase of Tecfidera, patient care and revenue could be compromised.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.
